Answer
Acarizax treats adults aged 18–65 diagnosed by history and positive skin-prick and/or specific-IgE testing with persistent moderate-to-severe house-dust-mite allergic rhinitis despite symptomatic medication, or house-dust-mite allergic asthma not well controlled by inhaled corticosteroids with mild-to-severe mite-allergic rhinitis; asthma requires careful evaluation before treatment.
Sources for this answer
- ACARIZAX 12 SQ-HDMALK-Abello Ltd · emc · SmPC §4.1 Therapeutic Indications · Version 5Document updated
Sources checked